Human olfactory bulb neural stem cells expressing hNGF restore cognitive deficit in Alzheimer's disease rat model

Journal of Cellular Physiology

Volumn 230, Issue 1, 2015, Pages 116-130

  Marei, Hany E S ^a   Farag, Amany ^a   Althani, Asma ^b   Afifi, Nahla ^c   Abd Elmaksoud, Ahmed ^a   Lashen, Samah ^a   Rezk, Shaymaa ^a   Pallini, Roberto ^d   Casalbore, Patrizia ^e   Cenciarelli, Carlo ^f  

^a Mansoura University   (Egypt)

^b Qatar University   (Qatar)

^c AIN SHAMS UNIVERSITY   (Egypt)

^d CATHOLIC UNIVERSITY   (Italy)

^e CNR   (Italy)

^f INSTITUTE OF TRANSLATIONAL PHARMACOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; IBOTENIC ACID; NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; HEK293 CELL LINE; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LENTIVIRUS INFECTION; MALE; MORRIS WATER MAZE TEST; NERVE CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLFACTORY BULB; RAT; RAT MODEL; ANGIOGENESIS; ANIMAL; BIOLOGICAL THERAPY; BIOSYNTHESIS; CELL LINE; CELL PROLIFERATION; CHOLINERGIC NERVE CELL; COGNITION DISORDERS; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; MAZE TEST; METABOLISM; OLIGODENDROGLIA; TRANSPLANTATION; WISTAR RAT;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL- AND TISSUE-BASED THERAPY; CHOLINERGIC NEURONS; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; HEK293 CELLS; HIPPOCAMPUS; HUMANS; IBOTENIC ACID; MALE; MAZE LEARNING; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTOR; NEURAL STEM CELLS; OLFACTORY BULB; OLIGODENDROGLIA; RATS; RATS, WISTAR;

EID: 84910068058     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24688     Document Type: Article

References (97)

1. Arendt T, Holzer M, Fruth R, Bruckner MK, Gartner U. 1995. Paired helical filament-like phosphorylation of tau, deposition of (beta)/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2A. Neuroscience 69:691-698.
2. Arsenijevic Y, Villemure JG, Brunet JF, Bloch JJ, Déglon N, Kostic C, Zurn A, Aebischer P. 2001. Isolation of multipotent neural precursors residing in the cortex of the adult human brain. Exp Neurol 12:48-62.
3. Björklund A, Lindvall O. 2000. Cell replacement therapies for central nervous system disorders. Nat Neurosci 3:537-544.
4. Bobinski MDE, Leon MJ, Tarnawski M, Wegiel J, Reisberg B, Miller DC, Wisniewski HM. 1998. Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer disease. Brain Res 805:267-269.
5. Brustle O, McKay RG. 1996. Neuronal progenitors as tools for cell replacement in the nervous system. Curr Opin Neurobiol 6:688-695.
6. Brustle O, Spiro A, Karram K, Choudhary K. 1997. In vitro generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci USA 94:14809-14814.
7. Buc-Caron H. 1995. Neuroepithelial progenitor cells explanted from human fetal brain proliferate and differentiate in vitro. Neurobiol Dis 2:37-47.
8. Calza L, Giuliani A, Fernandez M, et al. 2003. Neural stem cells and cholinergic neurons:regulation by immunolesion and treatment with mitogens, retinoic acid, and nerve growth factor. Proc Natl Acad Sci USA 100:7325-7330.
9. Casalbore P, Budoni M, Ricci-Vitiani L, Cenciarelli C, Petrucci G. 2009. Tumorigenic potential of olfactory bulb-derived human adult neural stem cells associates with activation of TERT and NOTCH1. PLoS One 4:e4434.
10. Cenciarelli C, Budoni M, Mercanti D, Fernandez E, Pallini R. 2006. In vitro analysis of mouse neural stem cells genetically modified to stably express human NGF by a novel multigenic viral expression system. Neurol Res 28:505-512.
11. Chen KS, Gage FH. 1995. Somatic gene transfer of NGF to the aged brain: Behavioral and morphological amelioration. J Neurosci 15:2819-2825.
12. Choi DW, Koh J, Peters YS. 1988. Pharmacology of glutamate neurotoxicity in cortical cell culture: attenuation by NMDA antagonists. J Neurosci 8:185-196.
13. Conner JM, Franks KM, Titterness AK, Russell K, Merrill DA, Christie BR, Sejnowski TJ, Tuszynski MH. 2009. NGF is essential for hippocampal plasticity and learning. J Neurosci 29:10883-10889.
14. Coyle JT, Price DL, DeLong MR. 1983. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science:219:1190.
15. Dunnett SB, Everitt BJ, Robbins TW. 1991. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci 14: 494-501.
16. Eriksson P, Perfilieva E, Bjork T, Alborn AM, Nordborg C, Peterson A. 1998. Neurogenesis in the adult human hippocampus. Nat Med 4:1313-1317.
17. Fangling X, Huasong G, Yilu G. 2011. Optimal time for passaging neurospheres based on primary neural stem cell cultures. Cytotechnology 63:621-631.
18. Fischer W, Wictorin K, Bjorklund A, Williams LR, Varon S, Gage FH. 1987. Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329:65-68.
19. Flax JD, Aurora S, Yang C, Simonin C, Wills AM, Billinghurst LL, Jendoubi M, Sidman RL, Wolfe JH, Kim SU, Snyder EY. 1998. Engraftable human neural stem cells respond to developmental cues, replace neurons and express foreign genes. Nat Biotechnol 16:1033-1039.
20. Good M, Bannerman D. 1997. Differential effects of ibotenic acid lesions of the hippocampus and blockade of N-methyl-D-aspartate receptor-dependent long-term potentiation on contextual processing in rats. Behav Neurosci 111:1171-1183.
21. Guldin WO, Markowitsch HJ. 1981. No detectable remote lesions following massive intrastriatal injections of ibotenic acid. Brain Res 225:446-451.
22. Guldin WO, Markowitsch HJ. 1982. Epidural kainate, but not ibotenate, produces lesions in local and distant regions of the brain. A comparison of the intracerebral actions of kainic acid and ibotenic acid. J Neurosci Methods 5:83-93.
23. Hefti F. 1986. Nerve growth factor (NGF) promotes survival of septal cholinergic neurons after fimbrial transection. J Neurosci 6:2155-2162.
24. Hermann A, Maisel M, Liebau S, et al. 2006. Mesodermal cell types induce neurogenesis from adult human hippocampal progenitor cells. J Neurochem 98:629-640.
25. Horner PJ, Gage PH. 2000. Regenerating the damaged central nervous system. Nature 407:963-970.
26. Hwang DH, Kim HM, Kang YM, Joo IS, Cho CS. 2011. Combination of multifaceted strategies to maximize the therapeutic benefits of neural stem cell transplantation for spinal cord repair. Cell Transplant 20:1361-1379.
27. Hwang DH, Lee HJ, Seok JI, Kim BG, Joo IS, Kim SU. 2009. Intrathecal transplantation of human neural stem cells over-expressing VEGF provides behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther 16:1234-1244.
28. Imitola J, Raddassi K, Park KI, Mueller J, Nieto M. 2004. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/ CXC chemokinem receptor 4 pathway. Proc Natl Acad Sci USA 101:18117-18122.
29. Jarrard LE. 1983. Selective hippocampal lesions and behavior: Effects of kainic acid lesions on performance of place and cue tasks. Behav Neurosci 97:873-889.
30. Johansson CB, Momma S, Clarke DL, et al. 1999. Identification of a neural stem cell in the adult mammalian central nervous system. Cell 96:25-34.
31. Kang UJ, Fisher LJ, Joh TH, O'Malley KL, Gage FH. 1993. Regulation of dopamine production by genetically modified primary fibroblasts. J Neurosci 13:5203-5211.
32. Kim S, deVellis UJ. 2009. Stem cell-based cell therapy in neurological diseases: A review. J Neurosci Res 87:2183-2200.
33. Kim SU, Park IH, Kim TH, Kim KS, Choi HB. 2006. Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease. Neuropathology 26:129-140.
34. Kim SU. 2004. Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 24:159-174.
35. Kirschenbaum B, Nedergaard M, Preuss A, et al. 1994. In vitro neuronal production and differentiation by precursor cells derived from the adult human forebrain. Cereb Cortex 4:576-589.
36. Köhler C, Schwarcz R, Fuxe K. 1979. Intrahippocampal injections of ibotenic acid provide histological evidence for a neurotoxic mechanism different from kainic acid. Neurosci Lett 15:223-228.
37. Koliatsos VE, Nauta HJ, Clatterbuck RE, Knüsel B, Burton LE, Hefti FF, Mobley WC, Price DI. 1991. Human nerve growth factor prevent prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol 30:831-840.
38. Kordower JH, Winn SR, Liu SR, Mufson EJ, Sladek JR, et al. 1994. The aged monkey basal forebrain: Rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Nat Acad Sci USA 91:10898-10902.
39. Kromer LF. 1987. Nerve growth factor treatment after brain injury prevents neuronal death. Science 235:214-216.
40. Kukekov VG, Laywell ED, Suslov O, Davies K, Scheffler B, Thomas LB,O'Brien TF, Kusakabe M, Steindler DA. 1999. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol 156:333-344.
41. Lee ST, Chu K, Jung KH, Kim SJ, Kim DH, et al. 2008. Anti-inflammatory mechanism ofm intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 131:616-629.
42. Lee HJ, Kim KS, Kim EJ, Choi HB, Lee KH. 2007. Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 25:1204-1212.
43. Lee HJ, Kim KS, Kim EJ, Park IH, Kim SU. 2007. Human neural stem cells overexpressing VEGF provides neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS One 1:e156.
44. Lee HJ, Lim IJ, Lee MC, Kim SU. 2010. Human neural stem cells genetically modified to overexpress BDNF promote functional recovery and neuroprotection in mouse stroke model. J Neurosci Res 88:3282-3294.
45. Lee HJ, Lim IJ, Park SW, Kim YB, Ko Y, Kim SU. 2012. Human neural stem cells genetically modified to express human nerve growth factor (hNGF) gene restore cognition in the mouse with ibotenic acidinduced cognitive dysfunction. Cell Transplant 212487-2496.
46. Lee HJ, Park IH, Kim HJ, Kim SU. 2009. Human neural stem cells overexpressing glial cell line derived neurotrophic factor (GDNF) promote functional recovery and neuroprotection in experimental cerebral hemorrhage. Gene Ther 16:1066-1076.
47. Luna L. 1968. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. New York, NY: McGraw-Hill. pp 114-115.
48. Mai K, Paxinos G, Assheuer K. 2003. Atlas of the human brain. 2nd edition. San Diego: Academic Press.
49. Marei HE, Ahmed AE. 2013. Transcription factors expressed in embryonic and adult olfactory bulb neural stem cells reveal distinct proliferation, differentiation and epigenetic control. Genomics 101:12-19.
50. Marei HES, Ahmed A-E, Michetti F, Pescatori M, Pallini R, et al. 2012. Gene expression profile of adult human olfactory bulb and embryonic neural stem cell suggests distinct signaling pathways and epigenetic control. PLoS One 7:e33542.
51. Marei HES, Althani A, Afifi N, Michetti F, Pescatori M, et al. 2011. Gene expression profilingof embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra. PLoS ONE 6:e28420.
52. Marei HES, Althani A, Afifi N, Abd-Elmaksoud A, Bernardini C, et al. 2013. Over-expression of hNGF in adult human olfactory bulb neural stem cells promotes cell growth and oligodendrocytic differentiation. PLoS One 8:e82206.
53. Martinez-Serrano A, Bjorklund A. 1997. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci 20:530-538.
54. Martinez-Serrano A, Fischer W, Bjorklund A. 1995. Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by NGF-secreting neural progenitors grafted to the basal forebrain. Neuron 15:473-484.
55. Martínez-Serrano A, Rubio FJ, Navarro B, Bueno C, Villa A. 2001. Human neural stem and progenitor cells: In vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS. Curr Gene Ther 1:279-299.
56. Mattson MP. 2001. Stem cells as therapeutics for neurodegenerative disorders? Expert Rev, Neurotherapeu 1:267-273.
57. Miettinen R, Kotti T, Tuunanen J, Toppinen A, Riekkinen PS, Halonen T. 1998. Hippocampal damage after injection of kainic acid into the rat entorhinal cortex. Brain Res 813:9-17.
58. Moe MC, Westerlund U, Varghese M, Berg-Johnsen J, Svensson M, Langmoen IA. 2005. Development of neuronal networks from single stem cells harvested from the adult human brain. Neurosurgery 56:1182-1188.
59. Murrell W, Feron F. 2005. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 233496-515.
60. Musial A, Bajda M, Malawska B. 2007. Recent development in cholinesterase inhibitors for Alzheimer's disease treatment. Curr Med Chem 14:2654-2679.
61. Nunes MC, Roy NS, Keyoung HM, et al. 2003. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med 9:439-447.
62. Pagano F, Impagnatiello F, Girelli M, Cova L,Grioni E, et al. 2000. Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 18:295-300.
63. Park KI, Ourednik J, Ourednik V, Taylor RM, Aboody KS, et al. 2002. Global gene and cell replacement strategies via stem cells. Gene Ther 9:613-624.
64. Park D, Lee HJ, Joo SS, Bae DK, et al. 2012. Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction. Exp Neurol 234521-526.
65. Reynolds BA, Weiss S. 1992. Generation of neurons and astrocytes from isolated cells from the adult mammalian central nervous system. Science 255:1707-1710.
66. Reynolds BA, Weiss S. 1996. Clonal and population analyses demonstrate that an EGF responsive mammalian embryonic CNS precursor is a stem cell. Dev Biol 175:1-13.
67. Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, Breakefield XO, Gage FH. 1988. Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242:1575-1578.
68. Rosenberg MB, Friedmann T, Robertson RC, Tuszynski M, Wolff JA, et al. 1988. Grafting genetically modified cells to the damaged brain: Restorative effects of NGF expression. Science 242:1575-1578.
69. Sah DW, Ray J, Gage F. 1997. Bipotent progenitor cell lines from the human CNS. Nat Biotech 15:574-580.
70. Salehi A, Delcroix JD, Swaab DF. 2004. Alzheimer's disease and NGF signaling. J Neural Transm 111:323-345.
71. Schumacher JM, Short MP, Hyman BT, Breakefield XO, Isacson O. 1991. Intracerebral implantation of nerve growth factor-producing fibroblasts protects striatum against neurotoxic levels of excitatory amino acids. Neuroscience 45:561-570.
72. Shihabuddin LS, Horner PJ, Ray J, Gage FH. 2000. Adult spinal cord stem cells generate neurons after transplantation in the adult dentate gyrus J. J Neurosci 20:8727-8735.
73. Shiras A, Chettiar ST, Shepal V, Rajendran G, Prasad GR. 2007. Spontaneous transformation of human adult non-tumorigenic stem cells to cancer stem cells is driven by genomic instability in a human adult model of glioblastoma. Stem Cells 25:1478-1489.
74. Snyder Y. 1994. Grafting immortalized neurons to the CNS. Curr OpinNeurobiol 4:742-751.
75. Srivastava N, Seth K, Khanna VK, Ansari RW, Agrawal AK. 2009. Long-term functional restoration by neural progenitor cell transplantation in mouse model of cognitive dysfunction: Cotransplantation with olfactory ensheathing cells for neurotrophic factor support. Int J Dev Neurosci 27:103-110.
76. Sun D, McGinn M, Hankins JE, Mays KM, Rolfe A, Colello R J. 2013. Aging-and injury-related differential apoptotic response in the dentate gyrus of the hippocampus inrats following brain trauma. Front Aging Neurosci 5:95.
77. Svendsen CN, Smith AG. 1999. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci 22:357-364.
78. Terry AV, Buccafusco JJ. 2003. The cholinergic hypothesis of age and Alzheimer's diseaserelated cognitive deficits: Recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821-217.
79. Terry RD, Davies P. 1980. Dementia of the Alzheimer's type. Annu Rev Neurosci 3:77-95.
80. Tourbah A, Linnington C, Bachelin C, Avellana-Adalid V, Wekerle H, Baron-Van Evercooren A. 1997. Inflammation promotes survival and migration of the CG4 oligodendrocyte progenitors transplanted in the spinal cord of both inflammatory and demyelinated EAE rats. J Neurosci Res 50:853-861.
81. Tuszynski MH. 2002. Gene therapy for neurodegenerative disorders. Lancet Neurol 1:51-57.
82. Tuszynski MH, Amaral DG, Gage FH. 1990. Nerve growth factor infusion in primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 10:3604-3614.
83. Tuszynski MH, Gage FH. 1991. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann Neurol 30:625-636.
84. Tuszynski MH, Roberts J, Senut MC, Gage FH. 1996. Gene therapy in the adult primate brain: Intraparenchymal grafts of cells genetically modified to produce nerve growth factor prevent cholinergic neuronal degeneration. Gene Ther 3:305-314.
85. Tuszynski MH, Thal L, Pay M, Salmon DP, Bakay R, et al. 2005. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer's disease. Nat Med 11:551-555.
86. Vescovi AL, Snyder EY. 1999. Establishment and properties of neural stem cell clones: plasticity in vitro and in vivo. Brain Pathol 569-598.
87. Villa A, Navarro B, Martínez-Serrano A. 2002. Genetic perpetuation of in vitro expanded human neural stem cells (HNSCs): cellular properties and therapeutic potential. Brain Res Bull 57:789-794.
88. Villa A, Rubio FJ, Navarro B, Bueno C, Martínez-Serrano A. 2001. Human neural stem cells in vitro. A focus on their isolation and perpetuation. Biomed Pharmacother 55:91-95.
89. Villa A, Snyder Y, Vescovi A, Martinez A. 2000. Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp Neurol 161:67-84.
90. Westerlund U, Moe MC, Varghese M, et al. 2003. Stem cells from the adult human brain develop into functional neurons in culture. Exp Cell Res 289:378-383.
91. Whitehouse PJ, Price DL, Struble RG, Clarkk AW. 1982. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215:1237-1239.
92. Whittemore R, Snyder Y. 1996. Physiological relevance and functional potential of central nervous system-derived cell lines. Mol Neurobiol 12:13-38.
93. Widy-Tyszkiewicz E, Piechal A, Gajkowska B, Smialek M. 2002. Tellurium-induced cognitive deficits in rats are related to neuropathological changes in the central nervous system. Toxicol Lett 131:203-214.
94. Williams LR. 1991. Hypophagia is induced by intracerebroventricular administration of nerve growth factor. Exp Neurol 113:31-37.
95. Winkler J, Ramirez GA, Kuhn HG, Peterson DA, Day-Lollini PA. 1996. Reversible induction of Schwann cell hyperplasia and sprouting of sensory and sympathetic neurites in vivo after continuous intracerebroventricular administration of nerve growth factor. Ann. Neurol 40:128-139.
96. Winkler J, Thal J. 1995. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA. Exp Neurol 136234-250.
97. Xuan AG, Long DH, Gu HG, Yang DD, Hong LP, Leng SL. 2008. BDNF improves the effects of neural stem cells on the rat model of Alzheimer's disease with unilateral lesion of fimbria-fornix. Neurosci Lett 440:331-335.